While our results clearly demonstrate that Keap1 hypomorphism in mice leads to Nrf2 overexpression and mitigation of experimental BPD, the exact mechanisms through which targeting Keap1 confers protection is unclear. The gene discussed is KEAP1; the disease is bronchopulmonary dysplasia.